These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 14742771)
1. Selection of atypical antipsychotics for the management of schizophrenia. Sprague DA; Loewen PS; Raymond CB Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771 [TBL] [Abstract][Full Text] [Related]
2. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials. Edwards SJ; Smith CJ Clin Ther; 2009 Jun; 31 Pt 1():1345-59. PubMed ID: 19698898 [TBL] [Abstract][Full Text] [Related]
3. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
4. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders? Motlová L; Spaniel F; Höschl C; Balon R Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853 [TBL] [Abstract][Full Text] [Related]
5. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Woods SW; Gueorguieva RV; Baker CB; Makuch RW Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728 [TBL] [Abstract][Full Text] [Related]
6. Second generation antipsychotics for schizophrenia. Feltus MS; Gardner DM Can J Clin Pharmacol; 1999; 6(4):187-95. PubMed ID: 10601752 [TBL] [Abstract][Full Text] [Related]
7. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial. Nasrallah HA J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522 [TBL] [Abstract][Full Text] [Related]
9. Treatments for late-life bipolar disorder. Aziz R; Lorberg B; Tampi RR Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540 [TBL] [Abstract][Full Text] [Related]
10. What do large scale studies of medication in schizophrenia add to our management strategies? Agius M; Davis A; Gilhooley M; Chapman S; Zaman R Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774 [TBL] [Abstract][Full Text] [Related]
11. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis. Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718 [TBL] [Abstract][Full Text] [Related]
12. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Lerner V; Libov I; Kotler M; Strous RD Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862 [TBL] [Abstract][Full Text] [Related]
13. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Gentile S Ann Pharmacother; 2004; 38(7-8):1265-71. PubMed ID: 15150376 [TBL] [Abstract][Full Text] [Related]
15. Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics. Stip E J Psychiatry Neurosci; 2000 Mar; 25(2):137-53. PubMed ID: 10740987 [TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of the efficacy of second-generation antipsychotics. Davis JM; Chen N; Glick ID Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218 [TBL] [Abstract][Full Text] [Related]
17. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482 [TBL] [Abstract][Full Text] [Related]
18. The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia. Isaac M; Koch A Eur Neuropsychopharmacol; 2010 Mar; 20(3):139-45. PubMed ID: 20053539 [TBL] [Abstract][Full Text] [Related]
19. A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo. Klemp M; Tvete IF; Skomedal T; Gaasemyr J; Natvig B; Aursnes I J Clin Psychopharmacol; 2011 Dec; 31(6):698-704. PubMed ID: 22020356 [TBL] [Abstract][Full Text] [Related]